reSee.it - Tweets Saved By @ShannonJoyRadio

@delbigtree - Del Bigtree

These numbers really hit me. 30% of the UK rejected this vaccine. This is the same number as in America, and the same number worldwide. Under the heaviest propaganda campaign in human history - under job threats, social pressure, guilt, and isolation - 30% of the world said no and held the line. We think of 30% as a small number. It isn't. There is zero apathy in that 30%. Every single one of those people made a hard, conscious, costly decision, and they made it completely alone, with no idea their neighbor was doing the exact same thing. That was the only thing that beat us. We weren't talking to each other. The employees who stood together as the 30% and said "we walk out if you force this" kept their jobs. Every one of them. Now think about the 70% who got it. How many of them actually believed in it? How many just broke under the pressure? At least half, I'd bet. Which means 50% of this world never wanted that vaccine. They didn't win because they were right. They won because they made us feel alone. You were never alone. You just didn't know it. Start talking. You are the change.

@DrJackKruse - ☣️ Pleb Kruse = BTC foundationalist in exile 🟩🔆

The warning letter to 23and Me was in 2013 and it said you cannot do what you are doing because you are practicing medicine without a license. At the same time Paula Casey Means is enrooled at Stanford trying to get a license. Mail-away genetic testing promised by Sergery Brin's wife at the time (2007), Anne Wojcicki to revolutionize the way that people learn about and manage their health. By 2014 a half a million Americans have sent their saliva to find out their risk of genetic disease — no doctors needed, or so Anne and Sergey thought. Sergey money paid for propaganda ads in print, social media and on TV by splashing ads across media nationwide in 2012-2013. It was 23andMe’s invitation to give you the ability to share your data with Anne and Sergery so they could discover “hundreds of things about your health,” and sell it to who ever would pay fo rit. It was BigTech creating the HARPA. This is where DARPA became HARPA. This was the time that PAula Casey Means was learning this business model. She worked at 23andMe back in those formative years. When the FDA blocked Anne's plan, then Paula realized maybe I need an MD afterall to play in the HARPA sandbox? Since 23andMe's inception in 2007, the government had allowed it to market and sell its at-home genetic tests free of regulation without any DEGREE. For $99 and the click of a mouse, 23andMe promised a “first step in prevention” to “mitigate serious diseases.” DARPA money from GOOGLE became HARPA. But in the winter of 2013, the Food and Drug Administration issued a letter forbidding sales of the test to diagnose health conditions unless there is evidence that it works for that purpose. Shortly after 23andMe announced that it had “suspended” all sales of its “health-related genetic tests to comply” with the FDA directive, consumers brought aclass action lawsuit against the company, alleging that it “falsely and misleadingly advertises” the genetic test “as providing ‘health reports on 240+ conditions'” in the absence of “analytical or clinical validation.” 2 months ago all Ms. Anne Wojcicki board members ALL resigned when she wanted to take the company public to sell data to make money. She is the only one left on the board. No one see her vision as GOOD for the public company. this means it is not good for you the public either. Can you guess why? Why is Paula still supporting Anne? Levels also sells BigTech ideas in her "metabolic framework" Note Levels Terms of Agreement before you put 2 and 2 together. See Cite 4 below. Anne Wojcicki submitted a proposal in late July 2024 to take the company private, after earlier expressing interest in acquiring the company back in April. The board’s Special Committee rejected her proposal, noting it didn’t provide a premium to the closing price at the time of 40 cents per share and it lacked committed financing. The Special Committee gave Wojcicki a “limited amount of additional time” to revise her proposal to take the company private. In their letter 2 months ago, however, the board members wrote, “After months of work, we have yet to receive from you a fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders.” Paula's friend is a data thief and no one wants to uphold her vision for HARPA. Will Paula try to enforce that as part of the new Washington DC force I call BigHARPA? We'll see. Anne is running a biological Ponzi scheme. I think Paula and her family might be investors in that idea. Why is DNA data worthless? Because mtDNA controls the epigenetic expression of nuclear DNA. This idea is buried at the base of decentralized science which is 180 degrees opposite centralized medicine ideas of 23andMe, Levels, and TrueMed. Investors have spoken loudly. So now the tables have turned into getting into seats in government where policy can change these market forces? We'll see soon. By the way, science has shown there is not much anyone can do with DNA data on their own, other than make Ponzi schemes investing into stupid things like 23andMe, and other HARPA companies then pumping and dumping the stock. This explains why a16z funded LEVELS. A16z specialized in shitcoins and pump and dump schemes. All bitcoiners know this. Admittedly, a Ponzi scheme can last a while and be profitable for some, who dump the stock ahead of others. This might be especially true if you can get a foot into Washington DC in some way. Even centralized medical scammer Scott Gottlieb’s Illumina, the flagship DNA sequencing company is struggling! Remember he is the regulator of the FDA who left government to work for Pfizer and then became a talking head on CNBC to shill his BigHarma bags. After the entire human genome can be sequenced for $100 – no growth. What, nobody needs their computer-generated garbage for anything, even when it only costs one Benjamin? Right @Kevin_McKernan ? High-flying “gene editing” companies spun from the most prestigious academic places are going bust left and right. Just do not use Brin's Google search engine. SEO is being used to help Anne. You can use Yandex search to find news articles like these daily: Tome Biosciences, a high-profile gene editing startup spun out of MIT, is halting its lab work and looking to sell itself or find a partner to continue developing its technology. The startup was at the vanguard of an emerging field of genetic medicinesdesigned to precisely insert entire genes into cells. The method promised to provide a nearly universal solution for treating genetic diseases and give scientists a powerful tool for creating cell therapies with supercharged abilities to fight cancer and autoimmune disease. But despite raising $213 million across two funding rounds, the three-year-old startup is running out of money. Since January, Tome has tried, and failed, to raise a third large round of funding needed to finish preclinical tests. What about the existential threat of making new weaponized viruses with the help of AI advertised by the GOF WEF propagandists on all sides of freedom? Turns out, AI is useless in making routine decisions in molecular design, such as figuring out which molecules would bind to target proteins. And we are talking about small chemical molecules, i.e. conventional drugs, not orders-of-magnitude larger and more complex biological constructs, i.e. proteins and “chimeric viruses”: Artificial intelligence models fail at predicting biology, results from a new AI competition suggest. Big Tech globalists are specialists in biological shitcoinery. Shortly after launching in April, a tiny startup in Utah called Leash Bio kicked off a challenge to test how accurately AI models predict molecules binding to specific protein targets. The results are in, Leash CEO Ian Quigley told media — and they aren’t good.“No one did well,” said Quigley, summing up the results of about 2,000 teams that competed over three months.For the competition, which ran on the data science competition platform Kaggle, Leash provided its training data, which consisted of lab results showing how millions of molecules bind — or don’t bind — to target proteins. Leash’s dataset is roughly 1,000 times larger than the largest publicly available database focused on protein-small molecule interactions, to Leash’s knowledge. Centralized medicine = HARPA = Metabolic medicine - nuclear DNA medicine. That is the wrong path to travels for anyone but it would be catastophic for MAHA, in my opinion. @JonesDanny CITES 1. https://natlawreview.com/article/fda-s-warning-letter-to-23andme-ethical-and-legal-issues 2.https://www.theguardian.com/science/2013/dec/03/23andme-suspends-marketing-fda-order 3.https://blog.23andme.com/articles/update-on-fda-letter 4. https://www.benzinga.com/pressreleases/24/09/g40908960/independent-directors-of-23andme-resign-from-board

FDA’s Warning Letter to 23andMe: Ethical and Legal Issues 23andMe, the maker of mail-order genetic tests, highlights the challenging legal and ethical issues posed by such products. While the FDA’s letter focuses on charges natlawreview.com

23andMe suspends marketing after failing to meet FDA requirements At-home genetic testing kits still for sale on company website while FDA questions claims made by marketing material theguardian.com

An Update Regarding The FDA's Letter to 23andMe 23andMe was started in 2007 with the belief that consumers have the right to get access to their genetic information and that information can help them 23andMe CEO and cofounder Anne Wojcicki updates customers concerning the FDA warning letter and regulatory guidelines. blog.23andme.com

Independent Directors of 23andMe Resign from Board - 23andMe Holding (NASDAQ:ME) SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- The independent directors of the Board of 23andMe Holding Co. (NASDAQ:ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, benzinga.com

@emeriticus - Pedro L. Gonzalez

Exclusive: Vivek Ramaswamy Supported COVID Segregation 🧵 “Could we tolerate a national system in which certain people on the basis of a biomarker are segregated?” That sounds like an excerpt from a science fiction novel about a medical dystopia. But it’s a quote from Vivek Ramaswamy, the biopharma entrepreneur and Republican presidential candidate. In April 2020, as the U.S. went into lockdown, Ramaswamy said he would be open to that kind of system to determine who could “go back to normal life.” He described it as an “inequity,” but concluded that “everyone stands to benefit from it.” Ramaswamy made the comments during an episode of Rockefeller Client Insights, the podcast of Rockefeller Capital Management. A concept like that is sharply at odds with the image of the civil libertarian he has cultivated during the primary. It also raises questions about his anti-establishment bona fides. During the podcast, Ramaswamy talked about different aspects of the coronavirus outbreak with Gregory J. Fleming, the president and CEO of Rockefeller Capital Management. Fleming asked him what a “path to normalcy” might look like, given what he described as a “potentially extended timeline” for the rollout of vaccines and treatments. The country was then more than 15 days into “15 days to slow the spread.” “One path to normalcy and a path that I’d like to see further progress made on is broad rollout of our antibody tests,” Ramaswamy said. He corrected himself and continued: “It’s not our company; I’m saying, as a society, rolling out the antibody tests such that we actually get our arms around what portion of the population is already immune through exposures that they may not have even known that they had. It might be 10 percent, it might be 20 percent, we might discover that it is some higher number. Those people are gonna be able to get back to work pretty quickly, get back to normal life because effectively they have the immunity badge, they have a badge in the form of their antibodies that protect them best we know from reinfection. On the flip side, you then have the people who don’t have immunity, and the question is those who are negative on the antibody tests, what happens with them? Now, this has been—I’ve had discussions in the last few days with policymakers, a couple of people in Congress, one U.S. Senator, and I think this is not lost on folks. But I think one early topic that’s come up is, could we tolerate a national system in which certain people on the basis of a biomarker are segregated? To say you can’t go back to normal life, where certain people get a head start. Is that an inequity we would tolerate? I personally think that it is better than the status quo if we can send 10 or 20 percent of the people back on the basis of having immunity that’s proven on the basis of a lab-based result that’s now available. That’s a good thing, and everyone stands to benefit from it.” A draft for discussion obtained by Contra shows Ramaswamy pitched this strategy to policymakers. “After its apex of COVID-19 cases, each state should start to administer universal antibody testing to determine which individuals have immunity to SARS-Cov-2 and which individuals do not,” he wrote. “Individuals with immunity can return to normal life, be released from social distancing practices, and help restart the economy.” “States should also have a well-designed plan for who should be released from social distancing norms to help revive the economy in advance of the availability of a COVID-19 vaccine,” he added. Read⤵️

@TuckerCarlson - Tucker Carlson

A man who claims he had sex with Barack Obama in 1999 tells his story. Wednesday. 6pm ET.

@JosBtrigga - Jose Vega — Vote Diane Sare!

To all my new followers: welcome! Here’s a thread of my other interventions and personal favorites! Starting with the (in)famous AOC confrontation… And if you’d like to support my work, please consider donating! Venmo: vegaistic (Cashapp: vegatastic) Paypal: vegaistic https://t.co/Ml6VfgtZ2z